You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 19, 2025

Drug Price Trends for GAS RELIEF


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for GAS RELIEF

Average Pharmacy Cost for GAS RELIEF

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
GAS RELIEF 180 MG SOFTGEL 70000-0566-01 0.05991 EACH 2024-12-18
GAS RELIEF (SIMETH) 80 MG CHEW 70000-0434-01 0.03062 EACH 2024-12-18
GAS RELIEF 125 MG CHEW TABLET 24385-0307-89 0.09075 EACH 2024-12-18
GAS RELIEF 125 MG SOFTGEL 00113-0428-65 0.06620 EACH 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for GAS RELIEF

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
GAS RELIEF Geri-Care Pharmaceutical Corp 57896-0799-01 100 1.65 0.01650 EACH 2021-09-18 - 2026-06-14 FSS
GAS RELIEF EXTRA STRENGTH Geri-Care Pharmaceutical Corp 57896-0694-03 30 1.34 0.04467 EACH 2024-03-06 - 2026-06-14 FSS
GAS RELIEF Geri-Care Pharmaceutical Corp 57896-0791-01 100 1.65 0.01650 EACH 2022-11-15 - 2026-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Medical Gases and Related Markets

Introduction to Medical Gases

Medical gases are essential components in the healthcare industry, used for various therapeutic, diagnostic, and surgical procedures. The demand for these gases is driven by several factors, including the rise in respiratory disorders, increasing surgical procedures, and advancements in medical technologies.

Market Size and Growth of Medical Gases

The global medical gases market was valued at $8.5 billion in 2022 and is projected to reach $16.7 billion by 2032, growing at a CAGR of 7% from 2023 to 2032[1][4].

Key Drivers of the Medical Gases Market

  • Rise in Respiratory Disorders: The increasing prevalence of respiratory diseases such as COPD and asthma significantly drives the demand for medical gases. For instance, the global prevalence of COPD is estimated to increase from 480 million cases in 2020 to 592 million by 2050[1].
  • Increase in Surgical Procedures: The growing number of surgical procedures also contributes to the demand for medical gases, particularly anesthetic gases.
  • Advancements in Medical Technologies: Improved healthcare infrastructure and advancements in medical technologies enhance the use and accessibility of medical gases.
  • Geriatric Population: The rising geriatric population, which is more prone to chronic disorders, further boosts the demand for medical gases[1].

Segmentation of the Medical Gases Market

By Product

The pure medical gases segment was the highest contributor to the market in 2022. This includes oxygen, nitrogen, and other pure gases used in various medical applications[1].

By Application

The therapeutics segment dominated the market in terms of revenue in 2022, driven by the surge in demand for medical gases used in treating various medical conditions, such as oxygen therapy for anemia and other respiratory issues[1].

By End User

The hospitals segment dominated the market in terms of revenue in 2022 due to the high demand for medical gases in hospital settings. However, the other segment, which includes home care and ambulatory care, is expected to experience the fastest growth rate during the forecast period[1].

Regional Analysis

  • North America: This region was the highest contributor to the market in 2022, driven by advanced healthcare infrastructure and high demand for medical gases.
  • Asia-Pacific: Expected to register the highest CAGR during the forecast period due to the expanding healthcare sector, increased government investment in healthcare infrastructure, and rising air pollution and smoking rates[1][4].

Price Projections and Market Trends

General Market Trends

The medical gases market is expected to grow significantly due to the increasing demand for oxygen and other medical gases, particularly in the wake of the COVID-19 pandemic. The pandemic has highlighted the critical need for constant oxygen support, especially in home care units and hospitals[4].

Price Inflation in Healthcare

While the medical gases market is growing, it is important to note that overall healthcare costs, including prescription drugs, are expected to rise. For example, employers predict an average increase of 8% in prescription drug costs in 2025, which could indirectly affect the pricing strategies in the medical gases market[2].

Comparison with Other Pharmaceutical Markets

Dyspepsia Drugs Market

The dyspepsia drugs market, though different in nature, also shows growth driven by increasing prevalence and an aging population. This market is expected to register a CAGR of 4.5% between 2024 and 2032, with proton pump inhibitors (PPIs) dominating the market[3].

Impact of Government Initiatives

Government initiatives, such as the Medicare drug price negotiation program, aim to lower drug prices. While these initiatives are primarily focused on prescription drugs, they can set a precedent for price negotiations in other healthcare segments, including medical gases. For instance, the Biden-Harris administration has negotiated lower prices for several expensive prescription drugs, which could influence pricing strategies across the healthcare sector[5].

Competitive Analysis

The medical gases market is competitive, with key players such as Air Liquide, Praxair, Atlas Copco, The Linde Group, and Airgas, Inc. These companies are investing in research and development to improve supply chains and distribution channels, and to develop new products and technologies[4].

Emerging Trends

  • Increased Use of Home Care Units: The COVID-19 pandemic has accelerated the use of medical gases in home care settings, which is expected to continue growing.
  • Advancements in Technology: Improvements in medical gas supply systems and storage technologies are enhancing the efficiency and safety of medical gas use.
  • Government Investments: Governments are investing in establishing oxygen plants and improving healthcare infrastructure, particularly in regions like Asia-Pacific[1][4].

Key Takeaways

  • The medical gases market is projected to grow significantly, driven by the rise in respiratory disorders and advancements in medical technologies.
  • The therapeutics segment and hospital end-user segment are key contributors to the market.
  • Asia-Pacific is expected to be the fastest-growing region due to expanding healthcare infrastructure and rising health issues.
  • Government initiatives and technological advancements are shaping the market dynamics.

FAQs

1. What is the projected growth rate of the global medical gases market?

The global medical gases market is projected to grow at a CAGR of 7% from 2023 to 2032[1].

2. Which segment dominated the medical gases market in terms of revenue in 2022?

The therapeutics segment dominated the market in terms of revenue in 2022[1].

3. Which region is expected to register the highest CAGR in the medical gases market?

The Asia-Pacific region is expected to register the highest CAGR during the forecast period[1].

4. How has the COVID-19 pandemic impacted the medical gases market?

The COVID-19 pandemic has increased the demand for medical gases, particularly oxygen, due to the high number of patients requiring constant oxygen support[4].

5. Which companies are key players in the medical gases market?

Key players include Air Liquide, Praxair, Atlas Copco, The Linde Group, and Airgas, Inc.[4].

Cited Sources

  1. Allied Market Research - Medical Gases Market Size, Growth | Statistics By 2032
  2. Managed Healthcare Executive - Employers Predict Drug Prices Will Increase in 2025, Survey Shows
  3. GMI Insights - Dyspepsia Drugs Market Size, Industry Analysis & Forecasts, 2032
  4. Persistence Market Research - Medical Gas Market Share and Growth Research Report 2032
  5. The White House - FACT SHEET: Biden-Harris Administration Announces New, Lower Prices for First Ten Drugs Selected for Medicare Price Negotiation to Lower Costs for Millions of Americans

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.